PMV Pharmaceuticals, Inc.（PMVP）内部人交易：高管与董事近期交易
过去 18 个月，共有 6 位内部人为 PMV Pharmaceuticals, Inc.（PMVP）报告了 9 笔 Form 4 交易（最近一笔 2025-10-29）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2025-10-29 | Mack David Henry | President and CEO | 买入 | 220,643 | $302,281 |
| 2025-10-27 | ORBIMED ADVISORS LLC | 10% 以上股东 | 卖出 | 1.0M | $1.5M |
| 2025-10-27 | OrbiMed Capital GP V LLC | 10% 以上股东 | 卖出 | 1.0M | $1.5M |
| 2025-09-12 | ORBIMED ADVISORS LLC | 10% 以上股东 | 卖出 | 500,000 | $900,000 |
| 2025-09-12 | OrbiMed Capital GP V LLC | 10% 以上股东 | 卖出 | 500,000 | $900,000 |
| 2025-07-03 | Carulli Michael | Chief Financial Officer | 卖出 | 28,249 | $29,944 |
| 2025-07-03 | Jalota Deepika | Chief Development Officer | 卖出 | 33,065 | $35,049 |
| 2025-07-03 | Mack David Henry | President and CEO | 卖出 | 58,411 | $61,916 |
| 2025-07-03 | Ticktin Robert | General Counsel & COO | 卖出 | 23,151 | $24,540 |
来源：SEC Form 4 申报文件 · 截至 2025-10-29